October 1, 2010
Hyatt Regency Washington on Capitol Hill
Washington, D.C.
Program Schedule
To view slides from a presenter click the icon next to the presentation title.
Friday, October 1, 2010 |
|
8:00 am - 8:15 am | ![]() George J. Weiner, MD - University of Iowa |
8:15 am - 10:05 am | Session 1: Tumor-Targeted Antibodies Chair: Ira Mellman, PhD - Genentech, Inc. Targeting Activated HER2 in Solid Tumors Mark X. Sliwkowski, PhD - Genentech, Inc. ![]() Louis M. Weiner, MD - Georgetown University Medical Center ![]() Paul M. Sondel, MD, PhD - University of Wisconsin, Madison |
10:30 am - 12:00 pm | Session 2: Immunomodulatory Antibodies Chair: Glenn Dranoff, MD - Dana-Farber Cancer Institute Immune Modulation by Antibody Lieping Chen, MD, PhD - Johns Hopkins University School of Medicine Immunomodulation with Antibodies Blocking the B7-H1/PD-1 Axis Suzanne L. Topalian, MD - Johns Hopkins University School of Medicine |
1:00 pm - 2:30 pm | Session 3: Investigating Antibodies as "Vaccines" Chair: Ira Mellman, PhD - Genentech, Inc. Antibody Therapeutics in Cancer: Converting Passive to Active Raphael Clynes, MD, PhD - Colubmia University ![]() Tibor Keler, PhD - Celldex Therapeutics, Inc. |
3:00 pm - 5:00 pm | Session 4: Antibody Engineering Chair: George J. Weiner, MD - University of Iowa ![]() Germaine Fuh - Genentech, Inc. ![]() Pablo Umaña, PhD - Roche Glycart AG ![]() Patrick A. Baeuerle, PhD - Micromet, Inc. |
Saturday, October 2 - Monday, October 4, 2010 |
|
iSBTc 25th Annual Meeting For more information, please click here. |
All presentations are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.